FDA Requests More Cardiovascular Safety Data for Pargluva

Drug Industry Daily
KEYWORDS FDA
A A

Merck and Bristol-Myers Squibb (BMS) must submit additional safety data to the FDA before their jointly developed diabetes drug Pargluva can gain final approval, the firms said Oct. 18.

To View This Article:

Login

Subscribe To Drug Industry Daily